Skip to content

A study to determine the Rate of Occurrence of Acute state of Confusion in Serious Cancer patients admitted in Intensive Care Unit(ICU)

Prospective study to determine incidence of delirium in critically ill cancer patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/019325
Enrollment
200
Registered
2019-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F05- Delirium due to known physiological condition

Interventions

Intervention1: Nil: nil Control Intervention1: nil: nil

Sponsors

Tata Memorial Hospital
Lead Sponsor
Not any
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with ICU admission 2.Adult patients (Age > 18 years) 3.Patients who could communicate with medical and paramedical staff in English / Hindi / Marathi languages

Exclusion criteria

Exclusion criteria: 1.Patients/relatives who refused consent for participation in study 2.Patients with diagnosed psychiatric disease 3.Patients on antipsychotic medications 4.Patients with severe dementia 5.Any CNS pathology or interventions 6.Discharge or death within 24 hours of ICU admission 7.Blind patient 8.Deaf patient

Design outcomes

Primary

MeasureTime frame
Presence of DeliriumTimepoint: every day till ICU discharge of occurrence of death

Secondary

MeasureTime frame
1. Risk factors associated with delirium in ICU as Demographic variables like age, sex, APACHE II on admission, anaemia, renal dysfunction, electrolyte disturbances, liver dysfunction, and sepsis. Type and stage of cancer, cancer therapy â??surgery, chemotherapy, radiation therapy .ICU Interventions â?? Ventilation, mobilization, medications (steroids, vasoactive drugs, sedatives and analgesics with their doses)Timepoint: once after completion of study;2. compare the current study result with previous study to to identify the risk factorsTimepoint: once after end of study

Countries

India

Contacts

Public ContactDr Nishanth Baliga

Tata Memorial Hospital

sheila150@hotmail.com09820156070

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026